LifeSci Advisors
LifeSci Advisors is a private professional services firm providing investor relations, non-deal roadshows, KOL events, and capital markets advisory to public and private healthcare and life sciences companies across North America, Europe, and Israel.
- Company typePrivate
- Founded2009
- HeadquartersNew York, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
What LifeSci Advisors does
LifeSci Advisors, LLC is a privately-held professional services firm headquartered in New York City that provides investor relations, capital markets advisory, and strategic communications services to public and private healthcare and life sciences companies. The firm self-describes as the largest integrated investor relations firm in healthcare, with global operations across 11 cities in North America (New York, Boston, San Francisco, San Diego, Chicago, Charlotte), Europe (London, Geneva, Paris, Milan), and Israel (Tel Aviv). Its core services are Non-Deal Roadshows (NDR), Corporate Communications, Capital Markets Advisory, KOL Events, and end-to-end Investor Relations Programs targeting institutional investors, family offices, and high-net-worth individuals through a network of more than 2,500 active institutional investor relationships.
The firm's offering is delivered through dedicated five-person client teams led by senior relationship managers, the majority of whom have 20+ years of healthcare capital markets experience and prior tenure at bulge-bracket and boutique banks (Jefferies, JP Morgan, UBS, Credit Suisse, Goldman Sachs, Canaccord) and at issuer-side IR functions. LifeSci does not develop proprietary technology products; instead, its competitive basis is human capital, institutional relationships, and an event-driven platform anchored by the annual LifeSci Corporate Access Event (CAE) and recurring KOL events.
Revenue is generated through quote-based professional services fees tied to scope of work, with no public pricing disclosure. The client base spans biotechnology, pharmaceutical, medical technology, and healthcare services companies across all development stages from pre-IPO through commercial, with documented outcomes including IPOs, private placements, secondary offerings, and M&A transactions totaling several billion dollars in aggregate deal value. The firm maintains operational links to LifeSci Partners and LifeSci Capital, with overlapping senior leadership and shared investor relationships.
LifeSci Advisors firmographics
Firmographics- Name
- LifeSci Advisors
- Legal name
- Lifesci Advisors, LLC
- Website
- https://lifesciadvisors.com
- Company type
- Private
- Founded year
- 2009
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- LifeSci Advisors is a private professional services firm providing investor relations, non-deal roadshows, KOL events, and capital markets advisory to public and private healthcare and life sciences companies across North America, Europe, and Israel.
- Ownership category
- akta.pro rank
LifeSci Advisors industry classification
Industry- Product category
- Healthcare Investor Relations
- NAICS
- Portfolio Management and Investment Advice (523940), Investment Banking and Securities Intermediation (523150)
- SIC
- Investment Advice (6282), Security Brokers, Dealers & Flotation Companies (6211)
- akta.pro primary industry
- Capital Raising Advisory (Equity & Equity-Linked) (FSAEAGAC)
- akta.pro secondary industry
- Private Client/High-Net-Worth Advisory (FSAEAAAN)
Keywords
Where LifeSci Advisors is headquartered
LocationHeadquarters
- HQ city
- New York
- HQ country
- United States
- HQ region
- North America
Offices11 records
Markets served
LifeSci Advisors business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Infrastructure, Technology or R&D, Others
Revenue model
- Investor Relations Advisory Services: LifeSci Advisors provides comprehensive investor relations programs to public and private healthcare companies. Services include strategic IR counsel, investor targeting, non-deal roadshows, KOL events, corporate communications, and capital markets advisory. The firm works with companies across all development stages from pre-IPO through commercial.
Go-to-market motion3 records
Distribution channels4 records
Marketing channels7 records
LifeSci Advisors product offering
Product offeringCore offering
LifeSci Advisors provides investor relations and capital markets advisory services to public and private healthcare and life sciences companies. Core offerings include Non-Deal Roadshows that connect clients with institutional investors, Corporate Communications programs for investor-facing materials and messaging, Capital Markets Advisory for IPOs and financings, KOL Events that engage leading clinical and scientific experts, and ongoing Investor Relations Programs covering investor targeting, communications strategy, and feedback collection.
Product overview
LifeSci Advisors is the largest integrated investor relations firm in healthcare, offering a suite of professional services rather than a software product. The core offerings include Non-Deal Roadshows (investor marketing to institutional investors across the U.S., Europe, and Israel), Corporate Communications (investor-facing materials and messaging development), Capital Markets Advisory (strategic counsel on accessing capital markets), KOL Events (key opinion leader gatherings for investor engagement), and comprehensive Investor Relations Programs. These services work together to help life sciences companies enhance their market presence, communicate effectively with investors, and access capital.
Differentiator
Problem solved
Functional benefit
Products and services
- Non-Deal Roadshows (NDR)
Quantifiable outcome
- Ambrx acquisition by Johnson & Johnson for $2.0 billion with 105% premium
- +13 more outcomes
Companies that use LifeSci Advisors
Customer profileNamed customers15 records
Segments3 records
Ideal customer profiles3 records
LifeSci Advisors technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
LifeSci Advisors partnerships and signals
Strategic signalScale indicators4 records
Recent moves6 records
Expansion highlights5 records
LifeSci Advisors competitors and assessment
Company assessmentBroad incumbents
- FTI Consulting (Healthcare & Life Sciences Strategic Communications): FTI Consulting's Strategic Communications segment runs a large healthcare and life sciences IR and corporate communications practice that competes head-to-head with LifeSci Advisors on mandates from biotech, medtech, and pharma clients (LifeSci's own Brian Ritchie is a former FTI Senior Director).
Direct peers
- ICR (ICR Inc.): ICR is a leading healthcare-focused public relations and investor relations advisory firm with a dedicated healthcare practice offering IR, corporate communications, and capital-markets advisory — closely mirroring LifeSci Advisors' core service stack and client base.
- Argot Partners: Argot Partners is a specialist healthcare and life sciences investor relations and corporate communications firm; LifeSci's Glenn Garmont is a former Argot SVP, evidencing direct talent overlap and competitive overlap on biotech IR mandates.
- Westwicke (an ICR company): Westwicke is a healthcare-focused IR and capital-markets advisory firm (now part of ICR) that directly competes for biotech and medtech IR mandates, with deep relationships among institutional healthcare investors.
- The Trout Group (now part of Solebury): The Trout Group is a healthcare-focused investor relations and capital-markets advisory firm; LifeSci's recent hire Tricia Truehart spent 8+ years there advising 30+ clients, evidencing direct competition for biotech IR mandates.
- The Ruth Group: The Ruth Group is a healthcare-focused investor relations firm specializing in private-company NDR programs with crossover and VC investors; LifeSci's Christopher Nardo and Ryan Gaitan both previously led NDR teams at The Ruth Group.
- KCSA Strategic Communications: KCSA is a strategic communications and investor relations firm with a dedicated healthcare practice; LifeSci's Garth Russell previously served as KCSA's Managing Director of Investor Relations overseeing the healthcare practice.
- Rx Communications: Rx Communications is a healthcare-specialist investor relations and corporate communications firm serving biotech, pharma, and medtech clients; LifeSci's Glenn Garmont previously served as Senior Vice President at Rx Communications.
- LaVoie Strategic Communications: LaVoie Strategic Communications (formerly LaVoieHealthScience) is an integrated investor relations and public relations agency for life sciences and biotech companies; LifeSci's Dory Kurowski previously led life-sciences IR engagements at LaVoie.
Emerging players
- Tiberend Strategic Advisors: Tiberend Strategic Advisors is a healthcare-focused investor relations and corporate communications firm serving biotech and medtech clients, competing for similar mandates to LifeSci Advisors in the mid-cap biotech segment.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
LifeSci Advisors social profiles
Digital presenceLifeSci Advisors financial estimates
Financial estimateRevenue estimate
Valuation estimate
LifeSci Advisors leadership team
Management profileNumber of profiles
Profiles14 records
LifeSci Advisors funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
LifeSci Advisors M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about LifeSci Advisors
What does LifeSci Advisors do?
LifeSci Advisors provides investor relations and capital markets advisory services to public and private healthcare and life sciences companies. Core offerings include Non-Deal Roadshows that connect clients with institutional investors, Corporate Communications programs for investor-facing materials and messaging, Capital Markets Advisory for IPOs and financings, KOL Events that engage leading clinical and scientific experts, and ongoing Investor Relations Programs covering investor targeting, communications strategy, and feedback collection.
Is LifeSci Advisors a public or private company?
LifeSci Advisors is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was LifeSci Advisors founded?
LifeSci Advisors was founded in 2009. It employs 11 to 50 people.
Where is LifeSci Advisors based?
LifeSci Advisors is headquartered in New York, United States, in the North America region.
How does LifeSci Advisors make money?
One revenue line is on record: investor Relations Advisory Services.
Who are LifeSci Advisors's main competitors?
FTI Consulting (Healthcare & Life Sciences Strategic Communications) is listed as a broad incumbent. Direct peers are ICR (ICR Inc.), Argot Partners, Westwicke (an ICR company), The Trout Group (now part of Solebury), The Ruth Group, KCSA Strategic Communications, Rx Communications and LaVoie Strategic Communications. Tiberend Strategic Advisors is listed as an emerging player.
Does LifeSci Advisors have an API?
No public API is recorded for LifeSci Advisors.
What industry is LifeSci Advisors in?
LifeSci Advisors's product category is Healthcare Investor Relations. Its primary akta.pro industry code is FSAEAGAC, Capital Raising Advisory (Equity & Equity-Linked), with a secondary code of FSAEAAAN, Private Client/High-Net-Worth Advisory. Its NAICS code is 523940 and its SIC code is 6282.